Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Cambridge Stories

2014-01-14 12:30:19

Company signs reseller agreement with DATEC, leading Korea reseller, as South Korean economy is poised for continued growth CAMBRIDGE, Mass., Jan. 14, 2014 /PRNewswire-iReach/ -- NuoDB, Inc., the leader in distributed database technology, today announced the signing of a reseller agreement with DATEC Corporation of Seoul, South Korea. DATEC is a technology and information-consulting firm for a host of brand name customers. (Photo:...

2014-01-14 12:27:32

CAMBRIDGE, Mass., Jan. 14, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today the creation of Onkaido Therapeutics, a new venture focused exclusively on developing mRNA-based oncology treatments. Onkaido Therapeutics will launch with $20 million in committed capital from Moderna. The new company will focus initially on 15...

2014-01-13 23:04:21

A new study by the Workers Compensation Research Institute (WCRI) examines the impact of the 30 percent reduction in the Illinois medical fee schedule that was enacted in 2011. Prior to the reduction, the Illinois fee schedule was one of the highest in the nation. Cambridge, MA (PRWEB) January 13, 2014 A new study by the Workers Compensation Research Institute (WCRI) examines the impact of the 30 percent reduction in the Illinois medical fee schedule that was enacted in 2011. Prior to the...

2014-01-13 08:29:57

CAMBRIDGE, Mass., Jan. 13, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2 monotherapy clinical trial in relapsed ovarian cancer. The ongoing open label Phase 2 monotherapy trial is being conducted at Massachusetts General Hospital and the affiliated Harvard teaching hospitals under the direction of principal investigator,...

2014-01-13 08:27:37

Clinical efficacy observed in first 10 patients CAMBRIDGE, Mass., Jan. 13, 2014 /PRNewswire/ -- Seres Health today announced interim results from a single-arm, open-label clinical trial evaluating its lead Ecobiotic(TM) candidate, SER-109, a microbial therapeutic developed for the treatment of recurrent Clostridium difficile infection (CDI), a bacterial infection that occurs following administration of antibiotics. So far, the initial data demonstrates an absence of recurrence of CDI...

2014-01-09 08:27:44

CAMBRIDGE, Mass., Jan. 9, 2014 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced that President and Chief Executive Officer, Thomas Hughes, Ph.D., is scheduled to present a company overview at the 32(nd) Annual J.P. Morgan Healthcare Conference. The conference is being held January 13 - 16, 2014, at the Westin St. Francis Hotel in San Francisco, California. Zafgen is scheduled to...

2014-01-09 08:26:53

- Industry Veterans Bring a Wealth of Commercial and Business Development Experience - CAMBRIDGE, Mass., Jan. 9, 2014 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced the appointment of Alicia Secor to the newly created position of Chief Commercial Officer, and the appointment of John L. LaMattina to the Company's Board of Directors. Ms. Secor joins Zafgen as an experienced health...

2014-01-08 08:32:53

CAMBRIDGE, Mass., Jan. 8, 2014 /PRNewswire-iReach/ -- The content marketing industry will be expanding in 2014. According to Curata, Inc.'s fourth annual benchmarks study, 2014 Content Marketing Tactics Planner: Creation, Curation and Syndication, 71% of marketers are increasing their content marketing investment in 2014, and 39% are increasing spend on curation. However, many organizations will find that it takes more than an increased budget to be successful as a content marketer....

2014-01-07 23:22:50

Auditor confirms that mBLAST’s system description is accurate and its controls were suitably designed. Cambridge, MA (PRWEB) January 07, 2014 mBLAST, the leading provider of web presence analytics, today announced that it has successfully completed the Type 1 SSAE 16 (Statement on Standards for Attestation Engagements) examination for its mPACT web presence analytics system. The Type 1 SSAE 16 examination was performed by an independent service audit firm in accordance with the...

2013-12-26 23:00:55

The Workers Compensation Research Institute (WCRI) announced today that it will host an hour-long webinar panel on Thursday, January 16, 2014 at 1pm ET (12pm CT, 11am MT, and 10am PT) to share lessons on how states can control the misuse and abuse of opioids. Cambridge, MA (PRWEB) December 26, 2013 The Workers Compensation Research Institute (WCRI) announced today that it will host an hour-long webinar panel on Thursday, January 16, 2014 at 1pm ET (12pm CT, 11am MT, and 10am PT) to share...